A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux; Heartburn
- Focus Therapeutic Use
- Sponsors AstraZeneca
Most Recent Events
- 05 Nov 2010 New trial record.